Nexelis

AIT Bioscience, LLC is a contract research organization based in Indianapolis, Indiana, that specializes in bioanalytical testing services for pharmaceutical and biotechnical companies. Founded in 2008, the company offers a range of services including pharmacokinetics/toxicokinetics bioanalysis, biomarker analysis, and immunogenicity assays to support preclinical and clinical studies. AIT Bioscience employs advanced techniques such as ligand-binding assays and LC-MS/MS analytics to provide comprehensive analyses for both large and small molecules. The organization also focuses on the development and validation of assays for investigational drug applications, ensuring real-time quality control and efficient sample logistics throughout the research process. As a subsidiary of Nexelis, AIT Bioscience is committed to delivering reliable and accurate bioanalytical data to aid in the advancement of new drug candidates.

ImmunXperts SA, founded in 2014 and based in Gosselies, Belgium, specializes in developing bioassays that focus on the human immune system. The company offers a comprehensive range of services, including immunogenicity assessments, immuno-oncology, and cell therapy. By providing in vitro, in vivo, and clinical services, along with in silico capabilities, ImmunXperts aids biopharma companies in evaluating immune responses in donors and patients. Their immunogenicity services are designed to support the drug development process by assessing the immunogenicity risk of biotherapeutics, enabling clients to outsource their immunology assessments and select tailored services to meet specific needs.